{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:56:29Z","timestamp":1790661389426,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.semnephrol.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T06:15:17Z","timestamp":1469686517000},"page":"273-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["The Patterns, Risk Factors, and Prediction of Progression in Chronic Kidney Disease: A Narrative Review"],"prefix":"10.1016","volume":"36","author":[{"given":"David","family":"Collister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Komenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Tangri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2016.05.004_bib1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the united states","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/j.ajkd.2013.12.012","article-title":"Cost-effectiveness of primary screening for CKD: a systematic review","volume":"63","author":"Komenda","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.ajkd.2011.11.044","article-title":"Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis","volume":"59","author":"O\u2019Hare","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/j.ajkd.2011.12.009","article-title":"Longitudinal progression trajectory of GFR among patients with CKD","volume":"59","author":"Li","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1681\/ASN.2013050464","article-title":"A within-patient analysis for time-varying risk factors of CKD progression","volume":"25","author":"Li","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/j.ajkd.2011.11.023","article-title":"Discussions of the kidney disease trajectory by elderly patients and nephrologists: a qualitative study","volume":"59","author":"Schell","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1053\/j.ajkd.2013.05.010","article-title":"Influence of urine creatinine concentrations on the relation of albumin-creatinine ratio with cardiovascular disease events: the multi-ethnic study of atherosclerosis (MESA)","volume":"62","author":"Carter","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib9","first-page":"S10","article-title":"Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT research group. Multiple risk factor intervention trial","volume":"63","author":"Grimm","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0002-8703(84)90763-4","article-title":"The prognostic significance of proteinuria: the Framingham study","volume":"108","author":"Kannel","year":"1984","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib11","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1681\/ASN.2005091012","article-title":"Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial","volume":"17","author":"Ishani","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2010.08.009","article-title":"Comparison of urinary albumin and urinary total protein as predictors of patient outcomes in CKD","volume":"57","author":"Methven","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1046\/j.1523-1755.1998.00874.x","article-title":"Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. \u201cGruppo italiano di studi epidemiologici in nefrologia\u201d (GISEN)","volume":"53","author":"Ruggenenti","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib14","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","article-title":"Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis","volume":"366","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib16","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/archinternmed.2009.284","article-title":"Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy","volume":"169","author":"Weinberg","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib17","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1523-1755.2004.00620.x","article-title":"Differential effects of calcium antagonist subclasses on markers of nephropathy progression","volume":"65","author":"Bakris","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib18","first-page":"4","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease","author":"Bolignano","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib19","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2014070688","article-title":"Reducing Albuminuria as Surrogate Endpoint (REASSURE) Consortium. Drug-induced reduction in albuminuria is associated with subsequent renoprotection: a meta-analysis","volume":"26","author":"Heerspink","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib20","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archinte.165.8.947","article-title":"The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension","volume":"165","author":"Lea","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib21","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1001\/archinte.161.9.1207","article-title":"Prevalence of high blood pressure and elevated serum creatinine level in the united states: findings from the Third National Health and Nutrition Examination Survey (1988-1994)","volume":"161","author":"Coresh","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0272-6386(96)90380-7","article-title":"Prevalence of hypertension in 1,795 subjects with chronic renal disease: the Modification of Diet in Renal Disease study baseline cohort. Modification of Diet in Renal Disease study group","volume":"28","author":"Buckalew","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.ajkd.2009.09.014","article-title":"Hypertension awareness, treatment, and control in adults with CKD: results from the chronic renal insufficiency cohort (CRIC) study","volume":"55","author":"Muntner","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-154-8-201104190-00335","article-title":"Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier","volume":"154","author":"Upadhyay","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib25","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010070.pub2","article-title":"Altered dietary salt intake for people with chronic kidney disease","volume":"2","author":"McMahon","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib29","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/ndt\/13.7.1682","article-title":"The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide","volume":"13","author":"Buter","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ki.2012.74","article-title":"Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers","volume":"82","author":"Lambers Heerspink","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ki.2013.401","article-title":"Bicarbonate therapy for prevention of chronic kidney disease progression","volume":"85","author":"Loniewski","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1681\/ASN.2014020205","article-title":"Current status of bicarbonate in CKD","volume":"26","author":"Dobre","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/ndt\/gfs609","article-title":"Serum bicarbonate and mortality in adults in NHANES III","volume":"28","author":"Raphael","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/j.ajkd.2014.05.008","article-title":"Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"64","author":"Driver","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib35","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.ajkd.2010.03.023","article-title":"Serum bicarbonate and long-term outcomes in CKD","volume":"56","author":"Menon","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","article-title":"Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the chronic renal insufficiency cohort (CRIC) study","volume":"62","author":"Dobre","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ki.2010.388","article-title":"Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans","volume":"79","author":"Raphael","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib38","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status","volume":"20","author":"de Brito-Ashurst","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib39","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ki.2014.83","article-title":"Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate","volume":"86","author":"Goraya","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2016.05.004_bib41","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1053\/j.ajkd.2007.12.018","article-title":"Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004","volume":"51","author":"Vassalotti","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib42","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/j.ajkd.2005.05.025","article-title":"Relationship of phosphorus and calcium-phosphorus product with mortality in CKD","volume":"46","author":"Menon","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib44","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.ajkd.2015.01.009","article-title":"Serum phosphorus and progression of CKD and mortality: a meta-analysis of cohort studies","volume":"66","author":"Da","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.ajkd.2009.06.004","article-title":"Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials","volume":"54","author":"Navaneethan","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib46","article-title":"Vitamin D compounds for people with chronic kidney disease not requiring dialysis","volume":"4","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib47","first-page":"12","article-title":"Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients","author":"Ballinger","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib48","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0272-6386(98)70135-0","article-title":"Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study","volume":"32","author":"O\u2019Dea","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib49","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1681\/ASN.V8121942","article-title":"Family history of end-stage renal disease among incident dialysis patients","volume":"8","author":"Freedman","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0272-6386(96)90356-X","article-title":"Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease","volume":"27","author":"Bergman","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib51","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0272-6386(95)90546-4","article-title":"Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus","volume":"25","author":"Freedman","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib52","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1681\/ASN.V971270","article-title":"Familial aggregation of renal disease in a population-based case-control study","volume":"9","author":"Lei","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib53","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib54","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib55","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib56","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/ndt\/gfr796","article-title":"APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease","volume":"27","author":"Tzur","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib57","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib58","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.ajkd.2010.05.018","article-title":"Genome-wide association studies in nephrology research","volume":"56","author":"Kottgen","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.107.746933","article-title":"Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF)","volume":"1","author":"Klein","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","article-title":"Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure","volume":"43","author":"Forman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCHEARTFAILURE.112.968230","article-title":"Blood urea nitrogen\/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure","volume":"6","author":"Brisco","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/eurjhf\/hfs209","article-title":"Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment","volume":"15","author":"Dupont","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib63","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/eurjhf\/hft036","article-title":"Fluid loss, venous congestion, and worsening renal function in acute decompensated heart failure","volume":"15","author":"Aronson","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","article-title":"Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival","volume":"122","author":"Testani","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib65","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nrneph.2013.108","article-title":"Biomarkers for incident CKD: a new framework for interpreting the literature","volume":"9","author":"Shlipak","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib66","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib67","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1681\/ASN.2014020218","article-title":"Serum fibroblast growth factor-23 is associated with incident kidney disease","volume":"26","author":"Rebholz","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1681\/ASN.2012070713","article-title":"Mineral metabolites and CKD progression in African Americans","volume":"24","author":"Scialla","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1681\/ASN.2014020218","article-title":"Serum fibroblast growth factor-23 is associated with incident kidney disease","volume":"26","author":"Rebholz","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib70","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.ajkd.2008.01.020","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage","volume":"52","author":"Bolignano","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib71","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2009.07.020","article-title":"NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis","volume":"54","author":"Haase","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ajkd.2012.02.336","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the atherosclerosis risk in communities (ARIC) study","volume":"60","author":"Bhavsar","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib73","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ki.2012.458","article-title":"Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease","volume":"83","author":"Liu","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib74","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/j.ajkd.2012.05.014","article-title":"Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the multi-ethnic study of atherosclerosis (MESA)","volume":"60","author":"Peralta","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ndt\/gfu085","article-title":"Biomarkers: more than just markers!","volume":"30","author":"Haase","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib76","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ki.2010.404","article-title":"Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-beta-D-glucosaminidase","volume":"79","author":"Vaidya","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib77","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.2013070758","article-title":"Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes","volume":"25","author":"Sabbisetti","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib78","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib79","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ng.377","article-title":"Multiple loci associated with indices of renal function and chronic kidney disease","volume":"41","author":"Kottgen","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib80","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.568","article-title":"New loci associated with kidney function and chronic kidney disease","volume":"42","author":"Kottgen","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib81","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1681\/ASN.2013070781","article-title":"Common variants in UMOD associate with urinary uromodulin levels: a meta-analysis","volume":"25","author":"Olden","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib82","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2369-12-2","article-title":"Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease","volume":"12","author":"Shlipak","year":"2011","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib83","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ki.2015.192","article-title":"Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults","volume":"88","author":"Garimella","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib84","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1074\/mcp.M110.001917","article-title":"Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease","volume":"9","author":"Good","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib85","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ki.2015.199","article-title":"Biomarkers of rapid chronic kidney disease progression in type 2 diabetes","volume":"88","author":"Looker","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib86","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/ndt\/gfu234","article-title":"The urinary proteome as correlate and predictor of renal function in a population study","volume":"29","author":"Gu","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib87","first-page":"249","article-title":"Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression","volume":"31","author":"Critselis","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib88","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/ndt\/gfu039","article-title":"Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy","volume":"29","author":"Siwy","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib89","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-158-8-201304160-00004","article-title":"Risk prediction models for patients with chronic kidney disease: a systematic review","volume":"158","author":"Tangri","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib90","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archinte.167.4.374","article-title":"SCreening for occult REnal disease (SCORED): a simple prediction model for chronic kidney disease","volume":"167","author":"Bang","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib91","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2215\/CJN.08590910","article-title":"Development and validation of a general population renal risk score","volume":"6","author":"Halbesma","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib92","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/jgs.12223","article-title":"A simple tool to predict end-stage renal disease within 1 year in elderly adults with advanced chronic kidney disease","volume":"61","author":"Drawz","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib93","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2007.07.006","article-title":"Predicting renal replacement therapy and mortality in CKD","volume":"50","author":"Johnson","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib94","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib95","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/ndt\/gft444","article-title":"A clinical stratification tool for chronic kidney disease progression rate based on classification tree analysis","volume":"29","author":"Rucci","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib96","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/ndt\/gft063","article-title":"Validation of the kidney failure risk equation in European CKD patients","volume":"28","author":"Peeters","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib97","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1053\/j.ajkd.2014.07.026","article-title":"Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK)","volume":"65","author":"Grams","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib98","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.ajkd.2008.04.026","article-title":"Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study","volume":"52","author":"Johnson","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib99","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","article-title":"Use and misuse of the receiver operating characteristic curve in risk prediction","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2016.05.004_bib100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951630033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951630033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:40:04Z","timestamp":1656895204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027092951630033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S027092951630033X"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.004","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Patterns, Risk Factors, and Prediction of Progression in Chronic Kidney Disease: A Narrative Review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}